Meeting Unmet Need for CLTI Treatment with Esprit™ BTK Scaffold System

Поделиться
HTML-код
  • Опубликовано: 27 янв 2025
  • Esprit™ BTK Everolimus Resorbable Scaffold System is an innovative new treatment for chronic limb-threatening ischemia (CLTI) patients that is designed to expand the luminal diameter of infrapopliteal lesions without the limitations of a permanent metallic implant.
    Learn more: bit.ly/45b3Ooh
    Important Safety Info: bit.ly/4dD39it
    Connect with us on social media:
    X - / abbottcardio
    LinkedIn - / abbott-cardiovascular

Комментарии •